Intercept Pharmaceuticals Company

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.
Employee Number:
501-1000
Founded Date:
2002
Funding Status:
IPO
Industry:
Metabolism Dysfunctions
Headquarters:
United States
Technology:
Cancer
Estimated Revenue:
$50M to $100M